: Declining reimbursements and the high cost of shifting to Value-Based Care (VBC) models make the financial backing of a large firm attractive. 3. The Impact: Cost, Quality, and Autonomy
After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management. private equity firms buying medical practices
The rapid consolidation of independent medical practices under private equity ownership. : Declining reimbursements and the high cost of
: PE provides the funds needed to upgrade electronic medical record (EMR) systems and invest in advanced diagnostic tools. This momentum has carried into 2026, driven by
: Most deals are now "bolt-ons"—small practices acquired to expand existing large platforms—which often fall below federal reporting thresholds, leading to "stealth consolidation". 2. The Driver: Why Doctors are Selling
The shift from physician-owned to corporate-owned care has drawn intense scrutiny due to several documented trends:
